THE BURDEN OF PREGNANCY HYPERGLYCEMIA IN INDONESIAN WOMENFitria, N., Utama, B., Pradipta, I., Schmidt, A., van Asselt, A. & Postma, M. J., 1-Oct-2018, In : Value in Health. 21, Supplement 3, p. S133-S134 2 p.
Research output: Contribution to journal › Meeting Abstract › Academic
Objectives: This study explores the burden of Hyperglycemia In Pregnancy (HIP) in Indonesian women using contemporary healthcare records. Methods: Healthcare records were extracted on pregnant women without pre-existing diabetes who were screened for HIP between 2014 and 2015 at two West Sumatera hospitals. Screening consisted of a Fasting Blood Glucose (FGB) test grouping women into Diabetes In Pregnancy (DIP) (glucose levels > 125 mg/dl), Gestational Diabetes Mellitus (GDM) (92-125 mg/dl), or normal glucose levels (<92 mg/dl); following the International Association of Diabetes in Pregnancy Study Groups (IADPSG) reference. Effect estimates and 95% Confidence Interval were determined using general and generalized linear models. Results: 3536 pregnant women were screened, of which 722 (21%) had HIP; 655 (19%) GDM and 67 (2%) DIP. HIP women did not have a significantly higher risk of death: OR 1.36 (95%-CI 0.71;2.62) for GDM and 0.90 (95%-CI 0.12;6.67) for DIP. We did observe a significantly lower neonatal death rate for children born of GDM women (3 (1%) compared to 178 (6%) in normal FBG women p-value > 0.01), which was not replicated when comparing DIP to normal FBG women (OR 0.58 95%-CI 0.26;1.29). Conclusions: Maternal outcomes did not seem to differ between HIP and normal FBG Indonesian women. The observed decrease in neonatal deaths in GDM women compared to normal FBG women, while not replicated in DIP, may be a result of intensified monitoring and delivery assistance offered.
|Number of pages||2|
|Journal||Value in Health|
|Issue number||Supplement 3|
|Publication status||Published - 1-Oct-2018|
|Event||International Society for Pharmacoeconomics and Outcomes Research - Barcelona, Spain|
Duration: 10-Nov-2018 → 14-Nov-2018
Conference number: 21
International Society for Pharmacoeconomics and Outcomes Research
10/11/2018 → 14/11/2018Barcelona, Spain
- adult, child, conference abstract, controlled study, female, human, hyperglycemia, Indonesian, major clinical study, monitoring, newborn, newborn death, newborn mortality, obstetric delivery, pregnancy diabetes mellitus, pregnant woman, statistical significance